Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,330
datasets available to search
ShareScore release 0.9.0
Dataset results
4,330 results for “Melanoma”
Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma
ClinicalTrials.gov study NCT00397982. IPD Sharing: NO. Countries: 1. Publications: 2.
Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by S
ClinicalTrials.gov study NCT00626405. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma
ClinicalTrials.gov study NCT01696045. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence
ClinicalTrials.gov study NCT04410445. IPD Sharing: UNDECIDED. Countries: 17. Publications: 1.
Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors
ClinicalTrials.gov study NCT03927742. IPD Sharing: NO. Countries: 1. Publications: 2.
Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov study NCT00003222. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma
ClinicalTrials.gov study NCT00518206. IPD Sharing: YES. Countries: 1. Publications: 2.
Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients
ClinicalTrials.gov study NCT00706992. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients
ClinicalTrials.gov study NCT04526730. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma
ClinicalTrials.gov study NCT00610311. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT01993719. IPD Sharing: YES. Countries: 1. Publications: 2.
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma
ClinicalTrials.gov study NCT02062359. IPD Sharing: NO. Countries: 1. Publications: 3.
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma
ClinicalTrials.gov study NCT01703507. IPD Sharing: Not stated. Countries: 1. Publications: 60.
Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab
ClinicalTrials.gov study NCT01515189. IPD Sharing: Not stated. Countries: 22. Publications: 3.
MK-3475 in Melanoma and NSCLC Patients With Brain Metastases
ClinicalTrials.gov study NCT02085070. IPD Sharing: NO. Countries: 1. Publications: 5.
A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
ClinicalTrials.gov study NCT01028222. IPD Sharing: Not stated. Countries: 14. Publications: 1.
Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma
ClinicalTrials.gov study NCT02263508. IPD Sharing: YES. Countries: 21. Publications: 4.
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
ClinicalTrials.gov study NCT03864042. IPD Sharing: NO. Countries: 5. Publications: 2.
Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT01134614. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II FANG™ in Advanced Melanoma
ClinicalTrials.gov study NCT01453361. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.